Cited by 263Gastrointestinal motility and disordersGut microbiota and healthMicroscopic Colitis

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome

Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., Sokol, H., Coffin, B., Sabaté, J. M.·2012·Neurogastroenterology & Motility

DOI 10.1111/j.1365-2982.2012.01893.x

Open this paper in CoChat — free account

Abstract

Background Irritable bowel syndrome (IBS) is a multifactorial disease for which a dysbiosis of the gut microbiota has been described. Bile acids (BA) could play a role as they are endogenous laxatives and are metabolized by gut microbiota. We compared fecal BA profiles and microbiota in healthy subjects (HS) and patients with diarrhea‐predominant IBS (IBS‐D), and we searched for an association with symptoms. Methods Clinical features and stool samples were collected in IBS‐D patients and HS. Fecal BA profiles were generated using HPLC coupled to tandem mass spectrometry. The fecal microbiota composition was assessed by q‐PCR targeting dominant bacterial groups and species implicated in BA transformation. Key Results Fourteen IBS‐D patients and 18 HS were included. The two groups were comparable in terms of age and sex. The percentage of fecal primary BA was significantly higher in IBS‐D patients than in HS, and it was significantly correlated with stool consistency and frequency. Fecal counts of all bacteria, lactobacillus, coccoides, leptum and Faecalibacterium prausnitzii were similar. There was a significant increase of Escherichia coli and a significant decrease of leptum and bifidobacterium in IBS‐D patients. Conclusions & Inferences We report an increase of primary BA in the feces of IBS‐D patients compared to HS, correlated with stool consistency and frequency. A dysbiosis of different bacterial groups was detected, some of them involved in BA transformation. As the gut microbiota is the exclusive pathway to transform primary into secondary BA, this suggests a functional consequence of dysbiosis, leading to lower BA transformation.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2982.2012.01893.x

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Functional Bowel Disorders
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Self-citation
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,423
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Self-citation
The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699
Colonic Secretion of Water and Electrolytes Induced by Bile Acids: Perfusion Studies in Man
Mekhjian, H. S., Phillips, S. F., & Hofmann, A. F. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106644 · Cited by 584
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR
Furet, J., Firmesse, O., Gourmelon, M., Bridonneau, C., Tap, J., Mondot, S., Dore, J. M., & Corthier, G. (2009) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2009.00671.x · Cited by 431
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers
Krogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L. G., Mäkivuokko, H., Kajander, K., & Palva, A. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-95 · Cited by 307

Flagged first, then by citations

Show all 42 references

Sorted by citations

Items 101–200 of 263

Gut Permeability, Its Interaction with Gut Microflora and Effects on Metabolic Health are Mediated by the Lymphatics System, Liver and Bile Acid
Tran, C. D., Grice, D. M., Wade, B., Kerr, C. A., Bauer, D. C., Li, D., & Hannan, G. N. (2015) · Future Microbiology · doi:10.2217/fmb.15.54 · Cited by 48
Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome
Wang, Z., Xu, C., Liu, Y., Wang, X., Zhang, L., Li, M., Zhu, S., Xie, Z., Wang, P., Duan, L.-P., et al. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000192 · Cited by 45
Probiotics in Irritable Bowel Syndrome
Quigley, E. M. M. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000348 · Cited by 41
Long-Term Evaluation of Biliary Reflux After Experimental One-Anastomosis Gastric Bypass in Rats
Bruzzi, M., Duboc, H., Gronnier, C., Rainteau, D. P., Couvelard, A., Gall, M. L., Bado, A., & Chevallier, J. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2577-x · Cited by 40
Self-citation
Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome
Singh, P., & Lembo, A. J. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.03.003 · Cited by 39
Gut Microbial Metabolites and Biochemical Pathways Involved in Irritable Bowel Syndrome: Effects of Diet and Nutrition on the Microbiome
James, C. S., Fraser, K., Young, W., McNabb, W. C., & Roy, N. C. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz302 · Cited by 41
Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review
Schmulson, M. J., Bielsa, M. V., Carmona-Sánchez, R., Hernández, A., López‐Colombo, A., López‐Vidal, Y., Peláez‐Luna, M., Remes-Troche, J. M., Tamayo, J. L., & Valdovinos, M. A. (2014) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.01.001 · Cited by 38
Metabolomics activity screening of T cell–induced colitis reveals anti-inflammatory metabolites
Montenegro-Burke, J. R., Kok, B. P., Guijas, C., Domingo-Almenara, X., Moon, C., Galmozzi, A., Kitamura, S., Eckmann, L., Sáez, E., Siuzdak, G. E., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abf6584 · Cited by 42
Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions
Camilleri, M., Oduyebo, I., & Halawi, H. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00242.2016 · Cited by 38
Concentrations of Fecal Bile Acids in Participants with Functional Gut Disorders and Healthy Controls
James, S. C., Fraser, K., Young, W., Heenan, P. E., Gearry, R. B., Keenan, J. I., Talley, N. J., Joyce, S. A., McNabb, W. C., & Roy, N. C. (2021) · Metabolites · doi:10.3390/metabo11090612 · Cited by 38
Bile Acids and the Potential Role in Primary Biliary Cirrhosis
Yang, H., & Duan, Z. (2016) · Digestion · doi:10.1159/000452300 · Cited by 35
Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review
Hou, J.-J., Wang, X., Wang, Y.-M., & Wang, B.-M. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.2018401 · Cited by 36
Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.
Camilleri, M., & Ford, A. (2017) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_102 · Cited by 33
Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation
Phan, J., Nair, D., Jain, S., Montagne, T., Flores, D. V., Nguyen, A., Dietsche, S., Gombar, S., & Cotter, P. (2021) · mSystems · doi:10.1128/msystems.01215-21 · Cited by 33
Pharmacological agents currently in clinical trials for disorders in neurogastroenterology
Camilleri, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70837 · Cited by 32
Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise—Searching for Gap Fillers in the Oxidative Stress Way of Thinking
Balmuș, I.-M., Ilie, O., Ciobica, A. S., Cojocariu, R.-O., Stanciu, C., Trifan, A. V., Cîmpeanu, M., CIMPEANU, C. S., & Gorgan, L. (2020) · Medicina · doi:10.3390/medicina56010038 · Cited by 34
Pathophysiology and Clinical Management of Bile Acid Diarrhea
Marasco, G., Cremon, C., Barbaro, M. R., Falangone, F., Montanari, D., Capuani, F., Mastel, G., Stanghellini, V., & Barbara, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113102 · Cited by 33
Role of bile acids in overweight and obese children and adolescents
Giannini, C., Mastromauro, C., Scapaticci, S., Gentile, C., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011994 · Cited by 32
Methodological issues in the study of intestinal microbiota in irritable bowel syndrome.
Taverniti, V., & Guglielmetti, S. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8821 · Cited by 32
Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?
Lê, A., Mantel, M., Marchix, J., Bodinier, M., Jan, G., & Rolli‐Derkinderen, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00002.2022 · Cited by 35
Irritable bowel syndrome: an integrated explanatory model for clinical practice
Hungin, A. P. S., Becher, A., Cayley, B., Heidelbaugh, J. J., Muris, J. W. M., Rubin, G. P., Seifert, B., Russell, A., & de Wit, N. J. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12524 · Cited by 33
Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias
Schmulson, M., Bielsa, M. V., Carmona-Sánchez, R., Hernández, A., López-Colombo, A., López Vidal, Y., Peláez-Luna, M., Remes-Troche, J. M., Tamayo, J. L., & Valdovinos, M. A. (2014) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2014.01.004 · Cited by 29
Lactiplantibacillus plantarum P9 for chronic diarrhea in young adults: a large double-blind, randomized, placebo-controlled trial
Yang, N., Ma, T., Xie, Y., Li, Q., Li, Y., Zheng, L., Li, Y., Xiao, Q., Sun, Z., Zuo, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51094-2 · Cited by 29
Diallyl Disulfide (DADS) Ameliorates Intestinal Candida albicans Infection by Modulating the Gut microbiota and Metabolites and Providing Intestinal Protection in Mice
Hu, W., Huang, L., Zhou, Z., Yin, L., & Tang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.743454 · Cited by 29
LncRNA XIST modulates 5-hydroxytrytophan-induced visceral hypersensitivity by epigenetic silencing of the SERT gene in mice with diarrhea-predominant IBS
Zhang, Y., Zhang, H., Zhang, W., Zhang, Y., Wang, W., & Nie, L. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109674 · Cited by 28
High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
Shiha, M. G., Ashgar, Z., Fraser, E. M., Kurien, M., & Aziz, I. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100465 · Cited by 27
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders
Lee, H. J., Choi, J., Ryu, H. S., Choi, C. H., Kang, E. H., Park, K. S., Min, Y. W., & Hong, K. S. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16124 · Cited by 29
Correlation between Peptacetobacter hiranonis, the baiCD Gene, and Secondary Bile Acids in Dogs
Lopes, B. C., Chen, C.-C., Sung, C., Ishii, P. E., Medina, L. F. D. C., Gaschen, F. P., Suchodolski, J. S., & Pilla, R. (2024) · Animals · doi:10.3390/ani14020216 · Cited by 27
Resistant starches from dietary pulses modulate the gut metabolome in association with microbiome in a humanized murine model of ageing
Kadyan, S., Park, G., Wang, B., Singh, P. R., Arjmandi, B. H., & Nagpal, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-37036-w · Cited by 27
Association of gut dysbiosis with intestinal metabolites in response to antibiotic treatment
Khan, T. J., Hasan, M. N., Azhar, E. I., & Yasir, M. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2018.11.004 · Cited by 26
Analysis of bile acids in human biological samples by microcolumn separation techniques: A review
Dosedělová, V., Itterheimová, P., & Kubáň, P. (2020) · Electrophoresis · doi:10.1002/elps.202000139 · Cited by 25
Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome
Yang, J., Wang, P., Liu, T., Lin, L., Li, L., Kou, G., Zhou, R., Li, P., & Li, Y. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02380-2 · Cited by 27
The effects of sulfated secondary bile acids on intestinal barrier function and immune response in an inflammatory in vitro human intestinal model
van der Lugt, B., Vos, M. C. P., Bromhaar, M. G., Ijssennagger, N., Vrieling, F., Meijerink, J., & Steegenga, W. T. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e08883 · Cited by 26
Gut microbiota and irritable bowel syndrome
Zhao, Y., & Zou, D. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13204 · Cited by 29
Bile acids and FXR in functional gastrointestinal disorders
Mosińska, P., Szczepaniak, A., & Fichna, J. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.05.016 · Cited by 30
Fecal Microbiota Characteristics in Constipation-Predominant and Mixed-Type Irritable Bowel Syndrome
Vladimirovna, G. M., Dmitrievna, S. Y., Burakova, I. Y., Morozova, P., Lagutina, S. N., Chizhkov, P. A., Korneeva, O. S., & Syromyatnikov, M. (2024) · Microorganisms · doi:10.3390/microorganisms12071414 · Cited by 29
A systemic combined nontargeted and targeted LC-MS based metabolomic strategy of plasma and liver on pathology exploration of alpha-naphthylisothiocyanate induced cholestatic liver injury in mice
Lin, S., Wang, T., Xu, H., Zhang, X.-N., Wang, Q., Liu, R., Li, Q., & Kai-shun, B. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.04.009 · Cited by 25
Role of Micronutrients and Gut Microbiota-Derived Metabolites in COVID-19 Recovery
Hernández-Flores, T. D. J., Pedraza‐Brindis, E. J., Cárdenas-Bedoya, J., Ruíz-Carrillo, J. D., Méndez-Clemente, A. S., Martinez-Guzman, M. A., & Íñiguez-Gutiérrez, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012324 · Cited by 25
Gut microbiota links with cognitive impairment in amyotrophic lateral sclerosis: A multi-omics study
Gong, Z., Ba, L., Tang, J., Yang, Y., Li, Z., Liu, M., Yang, C., Ding, F., & Zhang, M. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220198 · Cited by 25
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury
Carr, D. F., Ayehunie, S., Davies, A., Duckworth, C. A., French, S., Hall, N., Hussain, S. A., Mellor, H. R., Norris, A. M., Park, B. K., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.01.002 · Cited by 26
Insulin alleviates murine colitis through microbiome alterations and bile acid metabolism
He, S., Li, J., Yao, Z., Gao, Z., Jiang, Y., Chen, X., & Peng, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04214-3 · Cited by 27
Butterflies in the gut: the interplay between intestinal microbiota and stress
Lai, T.-T., Liou, C.-W., Tsai, Y.-H., Lin, Y.-Y., & Wu, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00984-6 · Cited by 26
Resistant Starch and Microbiota-Derived Secondary Metabolites: A Focus on Postbiotic Pathways in Gut Health and Irritable Bowel Syndrome
Kovács, E., Szabo, K., Varvara, R.-A., Uifălean, A., Cozma, A., Vulturar, R., Sitar-Tăut, A., Gabbianelli, R., Myhrstad, M. C. W., Telle‐Hansen, V. H., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167753 · Cited by 28
Alterations in the gut microbiota and metabolic profiles coincide with intestinal damage in mice with a bloodborne Candida albicans infection
Hu, W., Xu, D., Zhou, Z., Zhu, J., Wang, D., & Tang, J. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104826 · Cited by 23
Bile acid–gut microbiota crosstalk in irritable bowel syndrome
Gu, Y., Li, L., Yang, M., Liu, T., Song, X., Qin, X., Xu, X. J., Liu, J., Wang, B., & Cao, H. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2058353 · Cited by 26
Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome
Choo, C. H., Mahurkar‐Joshi, S., Dong, T. S., Lenhart, A., Lagishetty, V., Jacobs, J. P., Labus, J. S., Jaffe, N., Mayer, E. A., & Chang, L. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00352.2021 · Cited by 24
Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
Dhonnabháín, R. N., Xiao, Q., & O’Malley, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.745190 · Cited by 25
Ameliorative effect of Aconite aqueous extract on diarrhea is associated with modulation of the gut microbiota and bile acid metabolism
Zhang, D., Cheng, H., Zhang, Y., Zhou, Y., Wu, J., Liu, J., Feng, W., & Peng, C. Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1189971 · Cited by 23
Luminal contents from the gut of colicky infants induce visceral hypersensitivity in mice
Eutamène, H., García‐Ródenas, C. L., Yvon, S., d'Aldebert, E., Foata, F., Berger, B. W., Sauser, J., Théodorou, V., Bergonzelli, G. E., & Mas, E. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12994 · Cited by 22
Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders
Darmanto, A. G., Yen, T., Jan, J., Linh, T. T. D., Taliyan, R., Yang, C. H., & Sheu, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107564 · Cited by 23
Narrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis
Tambovtseva, R. S., ARSLAN, L., Grigoryeva, T., Abdulkhakov, S. R., Doludin, Y. V., Стома, И. О., Rizvanov, A. A., Рифкатовна, М. Р., & Gabdoulkhakova, A. G. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00210-24 · Cited by 23
Close association between intestinal microbiota and irritable bowel syndrome
Fan, W.-T., Ding, C., Xu, N., Zong, S., Ma, P., & Gu, B. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3060-2 · Cited by 24
Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study
Wei, W., Wang, H., Zhang, Y., Zhang, Y., Niu, B.-Y., Chen, S., Zhang, W., & Yao, S. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.04.022 · Cited by 23
The Protective Effect of Roseburia faecis Against Repeated Water Avoidance Stress-induced Irritable Bowel Syndrome in a Wister Rat Model
Choi, S. I., Kim, N., Nam, R. H., Jang, J. Y., Kim, E. H., Ha, S., Kang, K. S., Lee, W., Choi, H., Kim, Y.-R., et al. (2023) · Journal of Cancer Prevention · doi:10.15430/jcp.2023.28.3.93 · Cited by 24
Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic Pouchitis
Santiago, P., Quinn, K. P., Chen, J., Friton, J. J., Rypstra, C. R., Kashyap, P., & Raffals, L. E. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad288 · Cited by 20
The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study
Mazzawi, T. R. E., Hausken, T., Refsnes, P. F., Hatlebakk, J. G., & Lied, G. A. (2022) · Microorganisms · doi:10.3390/microorganisms10091819 · Cited by 20
Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing
Chiu, C.-M., Lin, F.-M., Chang, T., Huang, W.-C., Liang, C., Yang, T., Wu, W.-Y., Yang, T.-L., Weng, S.-L., & Huang, H. (2014) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-4-1 · Cited by 19
The Future of Probiotics for Disorders of the Brain-Gut Axis
Quigley, E. M. M., & Shanahan, F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_19 · Cited by 18
The Mechanism of Antimicrobial Activity of Conjugated Bile Acids against Lactic Acid Bacilli
Chai, L., Wu, H. J., Wang, X., He, L., & Guo, C. (2023) · Microorganisms · doi:10.3390/microorganisms11071823 · Cited by 18
Metabolic Bile Acid Profile Impairments in Dogs Affected by Chronic Inflammatory Enteropathy
Comito, R., Porru, E., Interino, N., Conti, M., Terragni, R., Gotti, R., Candela, M., Simoni, P., Roda, A., & Fiori, J. (2023) · Metabolites · doi:10.3390/metabo13090980 · Cited by 22
The role of gut microbiota in the treatment of irritable bowel syndrome
Leylabadlo, H. E., Heravi, F. S., Soltani, E., Abbasi, A., Kafil, H. S., Parsaei, M., Sanaie, S., Ahmadian, Z., & Ghotaslou, R. (2021) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000284 · Cited by 16
Total glycosides contribute to the anti-diarrheal effects of Qiwei Baizhu Powder via regulating gut microbiota and bile acids
Xie, G., Deng, N., Zheng, T., Peng, X., Zhang, S., & Tan, Z. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945263 · Cited by 16
Influence of high-fat diet on host animal health via bile acid metabolism and benefits of oral-fed Streptococcus thermophilus MN-ZLW-002
Luo, Y., Cheng, R., Liang, H., Miao, Z., Wang, J., Zhou, Q., Chen, J., He, F., & Shen, X. P. (2022) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.21-0182 · Cited by 15
Inhibition of CFTR‐mediated intestinal chloride secretion as potential therapy for bile acid diarrhea
Duan, T., Çil, O., Tse, C., Sarker, R. I., Lin, R., Donowitz, M., & Verkman, A. S. (2019) · The FASEB Journal · doi:10.1096/fj.201901166r · Cited by 18
Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China
Yao, C., Li, Y., Luo, L., Xie, F., Xiong, Q., Li, T., Yang, C., & Feng, P. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07500-0 · Cited by 17
Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
Goepp, J. G., Fowler, E., Mcbride, T., & Landis, D. L. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2013.099 · Cited by 15
Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption
Kårhus, M. L., Sonne, D. P., THOMASEN, M. L., Ellegaard, A., Holst, J. J., Rehfeld, J. F., Chávez‐Talavera, O., Tailleux, A., Staels, B., Nielsen, D. S., et al. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2021.12.007 · Cited by 14
Capacity of a Microbial Synbiotic To Rescue the In Vitro Metabolic Activity of the Gut Microbiome following Perturbation with Alcohol or Antibiotics
Tierney, B. T., den Abbeele, P. V., Al‐Ghalith, G. A., Verstrepen, L., Ghyselinck, J., Calatayud, M., Marzorati, M., Abdel-Gadir, A., Daisley, B. A., Reid, G., et al. (2023) · Applied and Environmental Microbiology · doi:10.1128/aem.01880-22 · Cited by 14
Bile Acids as Key Mediators of the Gut Microbiota–Immune Axis: Potential Biomarker and Therapeutic Perspectives
Baldi, S., Turrini, M., Cei, F., Menicatti, M., Bartolucci, G., & Amedei, A. (2026) · BioFactors · doi:10.1002/biof.70078 · Cited by 13
Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota
Jia, F., Du, L., He, J., Zhang, Z., Hou, X., Dong, Q., Bian, Z., & Zhao, L. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118256 · Cited by 17
Host genetics drives differences in cecal microbiota composition and immune traits of laying hens raised in the same environment
Lecoeur, A., Blanc, F., Gourichon, D., Bruneau, N., Burlot, T., Laan, M.-H. P.-V. D., & Calenge, F. (2024) · Poultry Science · doi:10.1016/j.psj.2024.103609 · Cited by 13
Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea
Ramos, G. P., & Camilleri, M. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07700-8 · Cited by 14
Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome
Deng, X., Xiao, L., Luo, M., Xie, P., & Xiong, L. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16159 · Cited by 16
Complementary Methodologies To Investigate Human Gut Microbiota in Host Health, Working towards Integrative Systems Biology
Méndez–García, C., Barbas, C., Ferrer, M., & Rojo, D. (2017) · Journal of Bacteriology · doi:10.1128/jb.00376-17 · Cited by 13
Beneficial effects of a probiotic blend on gastrointestinal side effects induced by leflunomide and amlodipine in a rat model
Song, S.-C., An, Y.-M., Shin, J., Chung, M.-J., Seo, J. G., & Kim, E. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0231 · Cited by 12
Controlled Delivery of Bile Acids to the Colon
Steiger, C., Phan, N. V., Sun, H., Huang, H., Hess, K., Lopes, A., Korzenik, J., Langer, R., & Traverso, G. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000229 · Cited by 12
An Overview and Proposed Research Framework for Studying Co-Occurring Mental- and Physical-Health Dysfunction
Hagerty, S. L., Ellingson, J. M., Helmuth, T. B., Bidwell, L. C., Hutchison, K. E., & Bryan, A. D. (2019) · Perspectives on Psychological Science · doi:10.1177/1745691619827010 · Cited by 12
Vitamin D receptor is overexpressed in the duodenum of patients with irritable bowel syndrome
Miura, K., Oshima, T., Ito, C., Horikawa, T., Yamada, M., Tomita, T., Fukui, H., & Miwa, H. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15225 · Cited by 11
Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls
Beinvogl, B. C., Manini, M. L., Camilleri, M., Donato, L. J., Harmsen, W. S., Absah, I., Burch, E., Schechter, N. L., & Nurko, S. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003067 · Cited by 11
Improvement of gastrointestinal health status in subjects consumingLactobacillus reuteriNCIMB 30242 capsules: apost-hocanalysis of a randomized controlled trial
Jones, M. L., Martoni, C., Ganopolsky, J. G., Sulemankhil, I., Ghali, P., & Prakash, S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.833601 · Cited by 11
Relationship Between the Gastrointestinal Side Effects of an Anti-Hypertensive Medication and Changes in the Serum Lipid Metabolome
Ahn, Y., Nam, M. H., & Kim, E. (2020) · Nutrients · doi:10.3390/nu12010205 · Cited by 11
Microbially derived polyunsaturated fatty acid as a modulator of gastrointestinal motility
Xiao, Y., & Kashyap, P. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161572 · Cited by 10
Gender Differences in the Gut Microbiome and How These Affect Cardiovascular Diseases
Rosel, A. C., Wassenaar, T. M., & Ussery, D. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-71135-5_7 · Cited by 10
Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review
Iribarren, C., Maasfeh, L., Öhman, L., & Simrén, M. (2022) · Gut Microbiome · doi:10.1017/gmb.2022.6 · Cited by 9
Rationale for Investigating Stool Metabolites and Microbiota in Women With Fecal Incontinence
Arya, L. A. (2017) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000751 · Cited by 8
In Vitro Evaluation of Probiotic Properties of Two Novel Probiotic Mixtures, Consti-Biome and Sensi-Biome
Jang, Y. J., Min, B., Lim, J. H., & Kim, B. (2023) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2303.03011 · Cited by 8
Shifts in the functional capacity and metabolite composition of the gut microbiome during recovery from enteric infection
Hansen, Z. A., Schilmiller, A. L., Guzior, D. V., Rudrik, J. T., Quinn, R. A., Vasco, K. A., & Manning, S. D. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1359576 · Cited by 7
The role of gut microbiota in diarrhea and its alleviation through microbiota-targeted interventions
Tian, R., Chong, C.-J., Bai, Y., Chen, N., Qiao, R.-R., Wang, K., Wang, Y., Zhao, P., Zhao, C., Tang, Y., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1630823 · Cited by 8
Improving Growth Dynamics of Faecalibacterium prausnitzii by Exposure to Prebiotics
Ahmed, S., Roberts, K. D., McCormick, T. S., & Ghannoum, M. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041698 · Cited by 8
Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
Mazzawi, T. R. E., Eikrem, Ø., Lied, G. A., & Hausken, T. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/3520686 · Cited by 8
Development of functional gastrointestinal disorder symptoms following laparoscopic cholecystectomy: a prospective cohort study
Chang, J. Y., Jung, H., Moon, C. M., Kim, S., Shim, K., Jung, S.-A., & Min, S. K. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1248465 · Cited by 6
[Significance of detection of biomarker fecal bile acids in the diagnosis and treatment of childhood Henoch-Schönlein purpura].
Hu, H., Duan, J., Zhao, B., Xiong, J., Liu, M., Cui, J., Ji, X., Zhang, T., Zhang, L.-Z., & Huang, Y. (2016) · PubMed Central · doi:10.7499/j.issn.1008-8830.2016.06.010 · Cited by 6
Healthcare associated diarrhea, not Clostridioides difficile
Turner, N., Saullo, J. L., & Polage, C. R. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000653 · Cited by 5
The role of bile acids and their TGR5 receptor in irritable bowel syndrome and diarrhoea
Walters, J. R. F. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.06.017 · Cited by 5
Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome
Xu, Y., Yao, R., Zhao, W., Zhu, J., Yao, J., Zhang, G., & Liu, D. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16544 · Cited by 5
Manipulating the Microbiome: An Alternative Treatment for Bile Acid Diarrhoea
Hillman, E. B. M., Rijpkema, S. G. T., Carson, D., Arasaradnam, R. P., Wellington, E. M. H., & Amos, G. C. A. (2021) · Microbiology Research · doi:10.3390/microbiolres12020023 · Cited by 5
Shared and disease-specific host gene-microbiome interactions across human diseasesPreprint
Priya, S., Burns, M. B., Ward, T., Mars, R. A. T., Adamowicz, E. M., Lock, E. F., Kashyap, P., Knights, D., & Blekhman, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.29.437589 · Cited by 5
Rol de los ácidos biliares en la diarrea crónica funcional y en el síndrome de intestino irritable con diarrea. Una revisión de la literatura
Tawil, J., Vaca, F., & Schmulson, M. J. (2021) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.21000003 · Cited by 4
Syndrome de l’intestin irritable
Lajoie, F., Rousseau, G., Blanquet‐Diot, S., & Etienne‐Mesmin, L. (2021) · médecine/sciences · doi:10.1051/medsci/2021095 · Cited by 5
Techniques for Phenotyping the Gut Microbiota Metabolome
Zubeldia‐Varela, E., Raczkowska, B. A., Ferrer, M., Pérez‐Gordo, M., & Rojo, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00004-x · Cited by 5

Authors: Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., Sokol, H., Coffin, B., & Sabaté, J. M.
Affiliations: Inserm (FR)
Corresponding author: Duboc, H.
ORCID: Duboc, H.
Rainteau, D.
Bouhassira, D.
Seksik, P.
Sokol, H.
Coffin, B.
Sabaté, J. M.
Venue: Neurogastroenterology & Motility
Publisher: Wiley
Published: 2012-02-22
Volume: 24
Issue: 6
Pages: 513
ISSN: 1350-1925 (ISSN-L)
1365-2982
DOI: 10.1111/j.1365-2982.2012.01893.x
OpenAlex: W1482883615
Cited by: 256
References: 42
Citations by year: 2026: 15 · 2025: 9 · 2024: 12 · 2023: 20 · 2022: 22 · 2021: 26 · 2020: 23 · 2019: 23 · 2018: 13 · 2017: 17 · 2016: 19 · 2015: 18 · 2014: 21 · 2013: 15 · 2012: 3
FWCI: 17.76
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Neurogastroenterology & Motility (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords: diarrhea-predominant irritable bowel syndrome, primary bile acids, fecal bile acids, gut dysbiosis, stool consistency, stool frequency, Escherichia coli, Faecalibacterium prausnitzii, Leptospirillum, Bifidobacterium, lactobacilli
MeSH terms: Adult, Bile Acids and Salts, Colon, Diarrhea, DNA, Bacterial, Feces, Female, Humans, Intestinal Mucosa, Male, Middle Aged, Irritable Bowel Syndrome, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks